Chemclin Diagnostics Co., Ltd.

Chemclin Diagnostics develops, produces, and sells clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.

Detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. Founded in 2007, the company is headquartered in Beijing, China.